Veloxis Pharmaceuticals A/S Announces Financial Results For The First Three Months Of 2014
HORSHOLM, Denmark, May 14, 2014 /PRNewswire/ --
Highlights:
-- The U.S. Food and Drug Administration (FDA) has accepted for standard review the company's New Drug Application (NDA) for Envarsus(R) for the prevention of organ rejection in adult kidney transplant patients.
Help employers find you! Check out all the jobs and post your resume.